When is treatment with a nonmacrolide indicated for community-acquired pneumonia (CAP)?

Updated: Oct 31, 2019
  • Author: Stephanie L Baer, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Answer

In regions with high rates of macrolide-resistant S pneumoniae, consider a nonmacrolide alternative.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!